DMII
$9.97+0.01 (+0.10%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Drugs Made In America Acquisition II Corp.
Recent News
NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave
MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and reconsider nuclear expansion, attention is turning to future uranium supply and how quickly projects like Rook I can begin production.
Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company
Key Insights Institutions' substantial holdings in Drugs Made In America Acquisition II implies that they have...